4.3 Article

Congenic mice reveal genetic epistasis and overlapping disease loci for autoimmune diabetes and listeriosis

Journal

IMMUNOGENETICS
Volume 66, Issue 7-8, Pages 501-506

Publisher

SPRINGER
DOI: 10.1007/s00251-014-0782-5

Keywords

Type 1 diabetes; Listeriamonocytogenes; Idd14; Idd31; Listr2; Congenic NOD mice

Funding

  1. Juvenile Diabetes Research Foundation [1-2008-602]
  2. Australian National Health and Medical Research Council [NHMRC: 575552, 1029231]
  3. Victorian Government's Operational Infrastructure Support Program
  4. Australian Postgraduate Award
  5. Australian NHMRC

Ask authors/readers for more resources

The nonobese diabetic (NOD) mouse strain serves as a genomic standard for assessing how allelic variation for insulin-dependent diabetes (Idd) loci affects the development of autoimmune diabetes. We previously demonstrated that C57BL/6 (B6) mice harbor a more diabetogenic allele than NOD mice for the Idd14 locus when introduced onto the NOD genetic background. New congenic NOD mouse strains, harboring smaller B6-derived intervals on chromosome 13, now localize Idd14 to an similar to 18-Mb interval and reveal a new locus, Idd31. Notably, the B6 allele for Idd31 confers protection against diabetes, but only in the absence of the diabetogenic B6 allele for Idd14, indicating genetic epistasis between these two loci. Moreover, congenic mice that are more susceptible to diabetes are more resistant to Listeria monocytogenes infection. This result co-localizes Idd14 and Listr2, a resistance locus for listeriosis, to the same genomic interval and indicates that congenic NOD mice may also be useful for localizing resistance loci for infectious disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available